A randomized trial of rosuvastatin in the prevention of venous thromboembolism. - Wikidata - wikimedia - TriplyDB

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

http://www.wikidata.org/entity/Q37262627

about

Statins for primary prevention of venous thromboembolism HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Statins for the primary prevention of cardiovascular disease Statins for primary prevention of venous thromboembolism Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Pleiotropic effects of statins Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation ROCKs as immunomodulators of stroke Hyperlipidemia, tissue factor, coagulation, and simvastatin Non-cardiovascular effects associated with statins Statins, inflammation and deep vein thrombosis: a systematic review Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring The epidemiology of venous thromboembolism Duration of anticoagulation for venous thromboembolic events CRP in cardiovascular disease The history and historical treatments of deep vein thrombosis Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility.Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.Atorvastatin-related thrombocytopenic purpura.Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial.Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences.Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2)C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort Current treatment of venous thromboembolism Gene variations of ROCKs and risk of ischaemic stroke: the Women's Genome Health Study.Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).Novel mediators and biomarkers of thrombosis.Inflammation and thrombosis in cardiovascular disease.C-reactive protein and venous thromboembolism: causal or casual association?Management of submassive pulmonary embolism.Anti-inflammatory therapies for cardiovascular disease New therapeutic targets for the antiphospholipid syndrome.Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study.Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.

P2860

Q24187238-BC96A0DD-3A4D-44C0-A394-508ED46481BB Q24194514-49D02966-8BC0-467C-8FA5-352FB17AD1C6 Q24201513-C064D497-7D67-4910-8B37-52AF86A05AA0 Q24204040-B520533D-09DC-4CD2-8F31-57C7B4792DAF Q24594814-1BB2733F-9456-4324-A670-CD2042984A0B Q24633010-36CBD338-56FA-469D-BE07-AAAD4AB0CCF1 Q26783220-1DDE0017-729A-4682-BDE1-AE74472FF2BB Q26825608-5C251850-12A0-4EE5-B9BA-F7C6C78A7822 Q26853214-37E9D15B-E29B-46DE-A6B8-10FAB0D54FF4 Q27024964-3608D08D-9467-4391-84CB-25F5CA6D546C Q27026332-FF39E01C-4119-481F-85EA-1456CBCC7F42 Q27027545-39095E0A-0A3F-43C2-B290-7A231FDB0E29 Q27317154-80A18DB0-1434-4163-A6EC-942DAC2A438F Q28067893-C3B4008F-E9B2-423D-90AA-1990AC778497 Q28081375-FD355D6D-8C90-4F3D-B851-A4B4BE655AF2 Q28268282-F28064AB-E2F4-4EE8-AC60-CD6E1AD3A531 Q28282887-AEBC661F-E57F-44FF-8268-342C01029892 Q28483807-877DD915-5CBF-4245-A842-B3154DC218FC Q30243926-C84E28A4-2A64-410E-B76F-8327616F01CC Q31141767-4CDDDBDF-9617-4F84-BC54-27C48168E6B7 Q33398180-2193A532-2B6A-46D7-ADD7-A3B09F6D06C4 Q33402096-009B5BEE-7476-4FAA-AEBC-291DE6CBDB2C Q33431611-16B3A84C-495E-46FA-9F64-AC323CB6A8ED Q33551467-DB0A14CC-F9DC-45F7-AC43-95B39A91AF2E Q33571213-3CADAE0F-0756-4F39-8DE8-63F7CA99F9C9 Q33574045-08D65C2A-3147-4B22-927F-758DBEDAE146 Q33587638-A10C0FC3-DC34-4045-8065-633352694D30 Q33605095-78836A04-4730-43B7-A630-D38E49418CE1 Q33736629-964A275E-4773-4422-87EB-DFFFF6F8086B Q33764027-F3373D39-9F1D-44D9-AE91-E418313D8D6E Q33826794-B5C34B86-5420-4353-A34F-2F1839425C00 Q33864040-9D969F25-71A6-4FF2-A7D5-A81D27F1420A Q33864069-11B66D28-C1CF-42F9-BE74-2F83B7904144 Q34130906-01C97382-110B-4462-99CF-D27B83466AB6 Q34135706-C9DC9B1A-AD0F-41B7-A0B4-CC7FF448E43E Q34137872-C54EA7B7-7690-440A-9658-3B1D0EEE6D6D Q34140319-94362452-7989-45D0-AA32-339FF289B8B2 Q34148677-473307CC-16CF-44A4-9C68-F35C11DD0ED1 Q34158442-7824601B-CEA0-44DA-81F5-77A597568E8A Q34293369-7B6BA808-0AF0-499A-BC31-72E05F966253

P2860

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

http://www.wikidata.org/entity/Q37262627

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

@en

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

@nl

type

label

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

@en

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

@nl

prefLabel

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

@en

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

@nl

P1433

Q37262627-D2C29FC7-5BA9-4A93-B26E-5396C8BCCEE7

P1476

Q37262627-F47FD285-2113-41C4-80D2-7E6F0C51195F

P2093

Q37262627-0FC6EA2A-979D-48CE-8EF1-4568F92AC227

Q37262627-14982E47-A925-48EC-8884-18BA6335A8CB

Q37262627-29D033B0-9744-4C07-9ED5-5A27729E5DC8

Q37262627-3604C170-2C18-473A-984C-9A51D9713A7B

Q37262627-49C7C020-359A-401E-A032-FDA21037CC8D

Q37262627-57A11D84-1CF7-403C-91C5-752840FC3A99

Q37262627-904BC969-8E23-4301-BD88-3A9283903CBF

Q37262627-C1EB9977-2C93-4A90-8257-372599FEC5D7

Q37262627-CD000AB2-C276-4079-816F-BB53AC4F642A

Q37262627-D455626F-0848-4266-A9C4-B644D2CD4FB6

P2860

Q37262627-04AF7935-A826-4AD9-8B82-DB1F093FEDAD

Q37262627-09454BB2-608B-49D6-B696-1EBBD32EEE50

Q37262627-147708C9-5AC3-4F18-B1BF-8F7A666526F1

Q37262627-1C79EBB0-7C73-47B6-B170-650A92454680

Q37262627-2DB15C6D-4D54-4D0E-9C33-4F2D48C81FC2

Q37262627-2EC32B47-915B-433F-9CDE-2274F8E6C3AD

Q37262627-308BBB8D-72DD-4B9B-AA3A-8C7B29F8B333

Q37262627-353FAC59-EAF5-4291-9CE2-45DA6141D10E

Q37262627-42707C76-C3C1-45CD-AF60-BCC3823105D0

Q37262627-472BA79F-65FE-4A66-8FD1-41212E236EA6

P304

Q37262627-147E45A9-8A96-454C-BFFD-B5A8C57F9129

P31

Q37262627-38B987E8-FD44-4798-8A23-19CC60FB4337

P356

Q37262627-CE3240F0-3DE2-4AB6-AE07-C248C75A05C9

P407

Q37262627-8CFEFCCB-5049-4989-98DC-E7CA1680B541

P433

Q37262627-F8593BC4-B63B-459F-A03E-F1C4AC77939C

P478

Q37262627-D06F7AAE-5FFE-45A0-90DE-1E0CF4AC7F0C

P50

Q37262627-04771BBC-9F08-40D0-8B09-A87BB749C474

Q37262627-1A7A7F94-D85B-4084-A584-A66634E169D1

Q37262627-29803115-3739-4EEE-9A6D-8A8C9B9DB3F8

Q37262627-338BF75B-4D93-4ED2-AEBC-FC3A752976B6

P577

Q37262627-B3F1CA02-9D8F-4187-9FAA-2CC55F8AA98B

P698

Q37262627-D4907C93-F7A3-415A-B198-F299CE60551F

P932

Q37262627-E7105395-E2D4-4B1B-9A81-E8274D44F8DA

P356

P1433

The New England Journal of Medicine

P1476

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

@en

P2093

Alberto J Lorenzatti

http://www.w3.org/2001/XMLSchema#string

Antonio M Gotto

http://www.w3.org/2001/XMLSchema#string

Eleanor Danielson

http://www.w3.org/2001/XMLSchema#string

Francisco A H Fonseca

http://www.w3.org/2001/XMLSchema#string

James Shepherd

http://www.w3.org/2001/XMLSchema#string

James T Willerson

http://www.w3.org/2001/XMLSchema#string

Jean G MacFadyen

http://www.w3.org/2001/XMLSchema#string

John J P Kastelein

http://www.w3.org/2001/XMLSchema#string

Paul M Ridker

http://www.w3.org/2001/XMLSchema#string

Robert J Glynn

http://www.w3.org/2001/XMLSchema#string

P2860

Use of statins and the subsequent development of deep vein thrombosis

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study

Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Calculating the number needed to treat for trials where the outcome is time to an event

A prospective study of risk factors for pulmonary embolism in women.

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

P304

1851-1861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0900241

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang Koenig

Børge G. Nordestgaard

Jacques Genest jr.

P577

2009-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19329822

http://www.w3.org/2001/XMLSchema#string

P932

2710995

http://www.w3.org/2001/XMLSchema#string